Glycochenodeoxycholic acid sodium salt
Cat. No.:YN373274
CAS No. :16564-43-5
产品名称: | Glycochenodeoxycholic acid sodium salt |
CAS No.: | 16564-43-5 |
Chemical Name: | N-[(3α,5β,7α)-3,7-Dihydroxy-24-oxocholan-24-yl]glycine Sodium Salt; N-[(3α,5β,7α)-3,7-Dihydroxy-24-oxocholan-24-yl]glycine Monosodium Salt; NSC 681056; Sodium Chenodeoxycholylglycine; Sodium Glycochenodeoxycholate; Sodium Glycochenodesoxycholate; |
Synonyms: | 甘氨鹅脱氧胆酸钠; Chenodeoxycholylglycine sodium salt; Sodium glycochenodeoxycholate |
分子量: | 471.61 |
分子式: | C₂₆H₄₂NNaO₅ |
SMILES: | C[C@@]12[C@](CC[C@]2([H])[C@H](C)CCC(NCC(O[Na])=O)=O)([H])[C@@]3([H])[C@]([C@@]4([C@](C[C@H](O)CC4)([H])C[C@H]3O)C)([H])CC1 |
存储: | Please store the product under the recommended conditions in theCertificate of Analysis. |
运输: | Room temperature in continental US; may vary elsewhere. |
产品描述: | Glycochenodeoxycholic acid sodium salt (Chenodeoxycholylglycine sodium salt) 是一种从脱氧鹅胆酸和甘氨酸在肝脏中形成的胆汁盐。它起到洗涤剂的作用,可溶解脂肪吸收,并本身被吸收。Glycochenodeoxycholic acid sodium salt (Chenodeoxycholylglycine sodium salt) 可诱导肝细胞凋亡。 |
IC50和靶点: | |
In Vitro: | |
In Vivo: | |
Clinical Trial: | |
Solvent & Solubility: |
Ollila, F., et al.: Langmuir, 17, 7107 (2001), Uekama, K., et al.: Chem. Pharm. Bull., 52, 900